By 2022, Cancer is Now a More Chronic Disease with Chronic Difficulties to Go Along with It
ArticleAçık Erişim
Özet
Cancer is a disease in which some body cells with genetic or epigenetic changes become capable of replicating and invading other regions of the body uncontrollably. Numerous functional abilities and features are acquired by these cells during this multistage neo¬plastic process. In the last 20 years, many agents have been discovered and used in the fight against cancer. However, the use of these drugs in appropriate patient groups is still a serious problem. Many cancer types are on the way to becoming chronic diseases; conscientious physi¬cians who are unable to provide appropriate treatment due to economic factors and other reasons face an additional burden. © 2022 by Turkish Society of Medical Oncology.
Anahtar Kelimeler
CancerChronic diseaseNovel drugsantibody drug conjugateantineoplastic agentneurotrophic tyrosine receptor kinase inhibitornicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase inhibitorprotein tyrosine kinase inhibitorunclassified drugArticlecancer chemotherapycancer immunotherapyeconomic aspecthumanmalignant neoplasmphysician
RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/12604Resmi atıflarda kullanılan kalıcı adresTam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Sumbul, Ahmet Taner | |
| dc.contributor.author | Sedef, Ali Murat | |
| dc.contributor.author | Karacin, Cengiz | |
| dc.contributor.author | Bilir, Cemil | |
| dc.contributor.author | Akagunduz, Baran | |
| dc.date.accessioned | 2026-10-18T20:27:29.115325301Z | |
| dc.date.available | 2026-10-18T20:27:29.115325301Z | |
| dc.date.issued | 2022 | |
| dc.description.abstract | Cancer is a disease in which some body cells with genetic or epigenetic changes become capable of replicating and invading other regions of the body uncontrollably. Numerous functional abilities and features are acquired by these cells during this multistage neo¬plastic process. In the last 20 years, many agents have been discovered and used in the fight against cancer. However, the use of these drugs in appropriate patient groups is still a serious problem. Many cancer types are on the way to becoming chronic diseases; conscientious physi¬cians who are unable to provide appropriate treatment due to economic factors and other reasons face an additional burden. © 2022 by Turkish Society of Medical Oncology. | |
| dc.identifier.doi | 10.37047/jos.2022-90068 | |
| dc.identifier.endpage | 6 | |
| dc.identifier.issn | 2651-4532 | |
| dc.identifier.issue | 1 | |
| dc.identifier.scopus | 2-s2.0-85132561183 | |
| dc.identifier.startpage | 1 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/12604 | |
| dc.identifier.volume | 8 | |
| dc.language.iso | en | |
| dc.publisher | Turkiye Klinikleri | |
| dc.relation.ispartof | Journal of Oncological Science | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Cancer | |
| dc.subject | Chronic disease | |
| dc.subject | Novel drugs | |
| dc.subject | antibody drug conjugate | |
| dc.subject | antineoplastic agent | |
| dc.subject | neurotrophic tyrosine receptor kinase inhibitor | |
| dc.subject | nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase inhibitor | |
| dc.subject | protein tyrosine kinase inhibitor | |
| dc.subject | unclassified drug | |
| dc.subject | Article | |
| dc.subject | cancer chemotherapy | |
| dc.subject | cancer immunotherapy | |
| dc.subject | economic aspect | |
| dc.subject | human | |
| dc.subject | malignant neoplasm | |
| dc.subject | physician | |
| dc.title | By 2022, Cancer is Now a More Chronic Disease with Chronic Difficulties to Go Along with It | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.scopus | 1 | |
| rdl.citation.trdizin | 0 | |
| rdl.department | T.C. SAĞLIK BAKANLIĞI | |
| rdl.department | SAĞLIK BİLİMLERİ ÜNİVERSİTESİ | |
| rdl.department | BAŞKENT ÜNİVERSİTESİ | |
| rdl.department | Özel Kuruluş | |
| rdl.department | ERZİNCAN BİNALİ YILDIRIM ÜNİVERSİTESİ | |
| rdl.oa.status | gold | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | TRDIZIN |
